CTNNB1 and alcoholic liver diseases: In contrast, the non-proliferative type was associated with CTNNB1 mutations, immune rejection, hepatitis C virus (HCV) and alcoholic liver disease, lower tumor grade, lower frequency of vascular invasion, and better prognosis [39–42].